Limited Use Note(s)

Government of Ontario Logo
SALMETEROL XINAFOATE50mcg Pd Inh-60 Dose Pk
Reason For Use CodeClinical Criteria
132For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
NOTE: This drug is not for relief of acute symptoms.
LU Authorization Period: Indefinite.
391For patients with moderate to severe COPD with persistent respiratory symptoms despite an adequate trial of, or an intolerance to, a regularly scheduled short-acting bronchodilator AND a long-acting anticholinergic.
LU Authorization Period: Indefinite.